ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000224251.2	ABT-263 (navitoclax)	Esophageal cancer	0.039920428	Sensitive
ENSG00000224251.2	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.012531257	Sensitive